A Geroscience Approach to Preventing Pathologic Consequences of COVID-19

Area of Science:

• Geroscience
• Infectious Diseases
• Immunology

Background:

• The COVID-19 pandemic highlights the vulnerability of older adults to severe disease and complications.
• Aging is a primary risk factor for severe COVID-19, linked to declining function and resilience.
• Existing treatments and vaccines primarily target acute SARS-CoV-2 infection, not age-related complications.

Purpose of the Study:

• To explore interventions preventing COVID-19 complications in older adults by targeting aging processes.
• To propose a geroscience-based strategy to enhance resilience against age-related infectious diseases.
• To develop a drug cocktail prototype for managing cytokine networks in infectious disease pandemics.

Main Methods:

• Conceptual framework based on geroscience principles.
• Analysis of shared aging pathways and cytokine networks in disease pathogenesis.
• Proposal for multi-target drug combinations to modulate aging processes.

Main Results:

• Drug combinations targeting aging processes can enhance resilience against infection-related complications.
• Modulating cytokine networks may prevent severe pathology in older adults.
• This approach complements existing COVID-19 treatments and vaccines.

Conclusions:

• Geroscience offers a unified approach to combat age-related diseases, including infectious disease complications.
• Targeting aging mechanisms can improve outcomes for vulnerable elderly populations during pandemics.
• A cytokine-focused drug cocktail could serve as a model for future pandemic preparedness.